434 related articles for article (PubMed ID: 29458430)
1. Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical cardiovascular magnetic resonance trial.
Muehlberg F; Arnhold K; Fritschi S; Funk S; Prothmann M; Kermer J; Zange L; von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
J Cardiovasc Magn Reson; 2018 Feb; 20(1):13. PubMed ID: 29458430
[TBL] [Abstract][Full Text] [Related]
2. Assessment of late gadolinium enhancement in nonischemic cardiomyopathy: comparison of a fast Phase-Sensitive Inversion Recovery Sequence (PSIR) and a conventional segmented 2D gradient echo recall (GRE) sequence--preliminary findings.
Elgeti T; Abdel-Aty H; Wagner M; Busjahn A; Schulz-Menger J; Kivelitz D; Dietz R; Hamm B
Invest Radiol; 2007 Oct; 42(10):671-5. PubMed ID: 17984763
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional phase-sensitive inversion recovery sequencing in the evaluation of left ventricular myocardial scars in ischemic and non-ischemic cardiomyopathy: comparison to three-dimensional inversion recovery sequencing.
Kido T; Kido T; Nakamura M; Kawaguchi N; Nishiyama Y; Ogimoto A; Miyagawa M; Mochizuki T
Eur J Radiol; 2014 Dec; 83(12):2159-2166. PubMed ID: 25311877
[TBL] [Abstract][Full Text] [Related]
4. Myocardial late gadolinium enhancement using delayed 3D IR-FLASH in the pediatric population: feasibility and diagnostic performance compared to single-shot PSIR-bSSFP.
Saprungruang A; Aguet J; Gill N; Tassos VP; Amirabadi A; Seed M; Yoo SJ; Lam CZ
J Cardiovasc Magn Reson; 2023 Jan; 25(1):2. PubMed ID: 36683053
[TBL] [Abstract][Full Text] [Related]
5. 3D whole-heart phase sensitive inversion recovery CMR for simultaneous black-blood late gadolinium enhancement and bright-blood coronary CMR angiography.
Ginami G; Neji R; Rashid I; Chiribiri A; Ismail TF; Botnar RM; Prieto C
J Cardiovasc Magn Reson; 2017 Nov; 19(1):94. PubMed ID: 29178893
[TBL] [Abstract][Full Text] [Related]
6. Motion-corrected free-breathing late gadolinium enhancement combined with a gadolinium contrast agent with a high relaxation rate: an optimized cardiovascular magnetic resonance examination protocol.
Yan C; Hu J; Li Y; Xie X; Zou Z; Deng Q; Zhou X; Bi X; Zeng M; Liu J
J Int Med Res; 2020 Oct; 48(10):300060520964664. PubMed ID: 33111603
[TBL] [Abstract][Full Text] [Related]
7. Late gadolinium enhancement cardiac imaging on a 3T scanner with parallel RF transmission technique: prospective comparison of 3D-PSIR and 3D-IR.
Schultz A; Caspar T; Schaeffer M; Labani A; Jeung MY; El Ghannudi S; Roy C; Ohana M
Eur Radiol; 2016 Jun; 26(6):1547-55. PubMed ID: 26373760
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium free cardiovascular magnetic resonance with 2-point Cine balanced steady state free precession.
Stromp TA; Leung SW; Andres KN; Jing L; Fornwalt BK; Charnigo RJ; Sorrell VL; Vandsburger MH
J Cardiovasc Magn Reson; 2015 Oct; 17():90. PubMed ID: 26520782
[TBL] [Abstract][Full Text] [Related]
9. A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data.
Engblom H; Tufvesson J; Jablonowski R; Carlsson M; Aletras AH; Hoffmann P; Jacquier A; Kober F; Metzler B; Erlinge D; Atar D; Arheden H; Heiberg E
J Cardiovasc Magn Reson; 2016 May; 18(1):27. PubMed ID: 27145749
[TBL] [Abstract][Full Text] [Related]
10. Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy.
Stirrat J; Joncas SX; Salerno M; Drangova M; White J
J Cardiovasc Magn Reson; 2015 Aug; 17(1):66. PubMed ID: 26248535
[TBL] [Abstract][Full Text] [Related]
11. A clinical combined gadobutrol bolus and slow infusion protocol enabling angiography, inversion recovery whole heart, and late gadolinium enhancement imaging in a single study.
Tandon A; James L; Henningsson M; Botnar RM; Potersnak A; Greil GF; Hussain T
J Cardiovasc Magn Reson; 2016 Oct; 18(1):66. PubMed ID: 27716273
[TBL] [Abstract][Full Text] [Related]
12. Bright-blood and dark-blood phase sensitive inversion recovery late gadolinium enhancement and T1 and T2 maps in a single free-breathing scan: an all-in-one approach.
Kellman P; Xue H; Chow K; Howard J; Chacko L; Cole G; Fontana M
J Cardiovasc Magn Reson; 2021 Nov; 23(1):126. PubMed ID: 34743718
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of dark-blood late gadolinium enhancement cardiovascular magnetic resonance without additional magnetization preparation.
Holtackers RJ; Van De Heyning CM; Nazir MS; Rashid I; Ntalas I; Rahman H; Botnar RM; Chiribiri A
J Cardiovasc Magn Reson; 2019 Jul; 21(1):44. PubMed ID: 31352900
[TBL] [Abstract][Full Text] [Related]
14. Myocardial late gadolinium enhancement: a head-to-head comparison of motion-corrected balanced steady-state free precession with segmented turbo fast low angle shot.
Fan H; Li S; Lu M; Yin G; Yang X; Lan T; Dai L; Chen X; Li J; Zhang Y; Sirajuddin A; Kellman P; Arai AE; Zhao S
Clin Radiol; 2018 Jun; 73(6):593.e1-593.e9. PubMed ID: 29548551
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of two dark blood methods of late gadolinium quantification of ischemic scar.
Foley JRJ; Broadbent DA; Fent GJ; Garg P; Brown LAE; Chew PG; Dobson LE; Swoboda PP; Plein S; Higgins DM; Greenwood JP
J Magn Reson Imaging; 2019 Jul; 50(1):146-152. PubMed ID: 30604492
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 3D phase-sensitive inversion-recovery and 2D inversion-recovery MRI at 3.0 T for the assessment of late gadolinium enhancement in patients with hypertrophic cardiomyopathy.
Morita K; Utsunomiya D; Oda S; Komi M; Namimoto T; Hirai T; Hashida M; Takashio S; Yamamuro M; Yamashita Y
Acad Radiol; 2013 Jun; 20(6):752-7. PubMed ID: 23473721
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine.
Rahsepar AA; Ghasemiesfe A; Suwa K; Dolan RS; Shehata ML; Korell MJ; Naresh NK; Markl M; Collins JD; Carr JC
Eur Radiol; 2019 Aug; 29(8):4357-4367. PubMed ID: 30617490
[TBL] [Abstract][Full Text] [Related]
19. Synthetic late gadolinium enhancement cardiac magnetic resonance for diagnosing myocardial scar.
Abdula G; Nickander J; Sörensson P; Lundin M; Kellman P; Sigfridsson A; Ugander M
Scand Cardiovasc J; 2018 Jun; 52(3):127-132. PubMed ID: 29544374
[TBL] [Abstract][Full Text] [Related]
20. [Application Value of Motion-correction Phase Sensitive Inversion Recovery (MOCO-PSIR) to Evaluate Myocardial Fibrosis in Patients with Heart Failure Caused by Dilated Cardiomyopathy].
Cheng W; Wang SM; He S; Wu T; Pan XL; Sun JY; Chen YC; Yu JQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 50(4):483-488. PubMed ID: 31642223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
